C. difficile screening can be cost effective in US hospitals

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.659, 2012-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C. difficile-associated diarrhoea imposes high cost burden in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

In the US, colorectal cancer screening is more cost effective in Blacks

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Colorectal cancer screening cost effective

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Adverse events cost US Medicare, hospitals dearly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Can preventive screening programmes for T2DM be cost effective in Germany?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite